Tomorrow at the stockholder's meeting is most likely time for announcement. Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Eastern Daylight Time) on Thursday, April 24.
The Federal Government should allow repatriation with a 3 to 5 % tax and the country would be flooded with cash. It is all money the treasury will never see without such a deal, so it is a win, win if they did that. Much better than overpaying for assets.
He also made up strange terms for things. Like Turtles and slow boats etc. I thought after he dropped the money in at the 2009 lows he could have quit on the quick profits.
Is that actually factual or just likely? I remember is celebration of becoming a self made millionaire and having several clients for whom he allegedly invested.
Where does Alan post? He was once one of the most prolific lame posters on the Yahoo finance pages.
It just lingers, falls, crawls etc. Anyone have a clue?
The problem isn't Al's fault. it takes to million in inheritance to make a self made millionaire. ;^)
nayyork's posts from yesterday are still there. Maybe I should have flagged that alias as well.
It appears many thought the news was negative due to "fuzzy" information regarding when they may approach the FDA for approval. It looks like I bought into PFE a bit too soon. The market sklide didn't help ...
With the markets sliding it is easy for large investors to run it down while slowly building positions. The news is great and soon as the market ends it's slide, PFE will perk up swiftly. Also look for upgrades as a possible catalyst. PFE is a huge stock and it is unclear to many how this cancer drug potential will affect it. It is possible it could get fast tracked and that would cause the sock to soar.
Sentiment: Strong Buy
Yet the Max pain remains at 25 on some sites and 25.5 for the monthly.
That is why it seems to be struggling. The entire markets are overbought. Selling short term calls may be the best answer
Intel Corporation (INTC) Upgraded By Piper Jaffray
by Paul SheaAugust 19, 2013, 12:39 pm
Apple Blows Away the Competition
By Ashraf Eassa | More Articles | Save For Later
April 1, 2014 | Comments (0)
iPhone 5s, powered by the Apple A7. Source: Apple.
When Apple (NASDAQ: AAPL ) announced that its iPhone 5s featured a 64-bit "desktop class" architecture, the press focused intensely on the "64-bit" aspect of the chip design. While the move to ARM's (NASDAQ: ARMH ) new, clean 64-bit instruction set certainly helped, the real "magic" was actually in some of the extremely smart design choices that Apple made when architecting the Cyclone CPU found inside of the A7. Thanks to a deep investigation by Anandtech (read it here), we now have even more evidence that Apple blew away the competition.
The benchmarks didn't lie
In the vast majority of benchmarks, Apple's 1.3 GHz Cyclone core offered performance that was roughly in line with a 2.4 GHz Intel (NASDAQ: INTC ) Silvermont and meaningfully higher than the various ARM Cortex A15 and Qualcomm (NASDAQ: QCOM ) Krait-based processors per processor core. Of course, Qualcomm and Intel are able to put four of these cores in roughly the same thermal envelope that Apple was able to put two of its cores, so the design trade-off was really "more cores" versus "more performance per core".
Of course, given that the vast majority of mobile applications likely can't make use of more than one core, let alone four cores, the design decision made absolute perfect sense. Indeed, it likely delivers the best user experience. Additionally, while the Android handset vendors need to differentiate among themselves with whiz-bang marketing features, Apple need not get involved in that sort of thing, although the "64-bit" marketing point didn't hurt. It can make the soundest technical decisions free from marketing constraints.
Was Apple really trying to replace Intel in the MacBook?
Given that the Apple Cyclone CPU core is extremely wide and, according to Anandtech, looks much more like a big core CPU from Intel